1. Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study. Issue 4 (April 2015) Authors: Calabrò, Luana; Morra, Aldo; Fonsatti, Ester; Cutaia, Ornella; Fazio, Carolina; Annesi, Diego; Lenoci, Marica; Amato, Giovanni; Danielli, Riccardo; Altomonte, Maresa; Giannarelli, Diana; Di Giacomo, Anna Maria; Maio, Michele Journal: Lancet Issue: Volume 3:Issue 4(2015) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study. Issue 4 (April 2015) Authors: Calabrò, Luana; Morra, Aldo; Fonsatti, Ester; Cutaia, Ornella; Fazio, Carolina; Annesi, Diego; Lenoci, Marica; Amato, Giovanni; Danielli, Riccardo; Altomonte, Maresa; Giannarelli, Diana; Di Giacomo, Anna Maria; Maio, Michele Journal: Lancet Issue: Volume 3:Issue 4(2015) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗